EBS Emergent BioSolutions Inc.: institutional ownership and insider trading
205 funds reported holding $424M of Emergent BioSolutions Inc. in their latest 13F filings; in Q2 2026 funds net bought $11.5M, with 30 new positions and 25 funds selling out; over the last 12 months insiders bought $0 and sold $1.26M on the open market; over its last four quarters it reported revenue of $770M and net income of −$177M.
EBS revenue and earnings
- Quarter ended Jun 30, 2026: revenue $234M, net income −$180M, EPS -3.49
- Quarter ended Mar 31, 2026: revenue $156M, net income $6.80M, EPS 0.07
- Quarter ended Dec 31, 2025: revenue $149M, net income −$54.6M, EPS -0.95
- Quarter ended Sep 30, 2025: revenue $231M, net income $51.2M, EPS 0.91
Famous investors holding EBS
- Renaissance Technologies (Renaissance Technologies): $5.73M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $8.98M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $7.54M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $4.09M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $1.36M, 0.0% of the portfolio
Largest institutional holders of EBS
- VANGUARD GROUP INC — $43.9M
- BlackRock, Inc. (BLK) — $39.5M
- DIMENSIONAL FUND ADVISORS LP — $25.8M
- STATE STREET CORP (STT, STT-PG) — $24.6M
- AMERICAN CENTURY COMPANIES INC — $23.2M
- VANGUARD CAPITAL MANAGEMENT LLC — $18.4M
- LSV ASSET MANAGEMENT — $14.2M
- ACADIAN ASSET MANAGEMENT LLC — $11.3M
- GEODE CAPITAL MANAGEMENT, LLC — $11.2M
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC — $10.1M
Recent EBS insider trades
- Oct 7, 2026: DeGolyer Donald W sold 17,800 shares ($126K)
- Oct 1, 2026: Williams Paul Anthony sold 3,000 shares ($19.6K)
- Jul 1, 2026: Williams Paul Anthony sold 3,000 shares ($25.2K)
- May 1, 2026: Dayal Sujata Tyagi sold 13,761 shares ($116K)
Members of Congress trading EBS
- Dec 11, 2024: Steve Cohen sold $1.00K–$15.0K
5%+ owners
- BlackRock, Inc.: 9.0% (Schedule 13G/A, filed Jul 28, 2026)
- Dimensional Fund Advisors LP: 5.3% (Schedule 13G, filed Apr 9, 2026)
Who owns the most EBS stock?
The largest institutional holders of Emergent BioSolutions Inc. in the latest 13F filings are VANGUARD GROUP INC ($43.9M), BlackRock, Inc. (BLK) ($39.5M), DIMENSIONAL FUND ADVISORS LP ($25.8M).
Are insiders buying or selling EBS?
Over the last 12 months insiders bought $0 and sold $1.26M of Emergent BioSolutions Inc. stock on the open market (SEC Form 4).
Which famous investors own EBS?
Renaissance Technologies, Izzy Englander, D. E. Shaw, Two Sigma, Ken Griffin.
What was EBS's revenue last quarter?
Emergent BioSolutions Inc. reported revenue of $234M for the quarter ended June 30, 2026, with net income of −$180M.
Which ETFs hold EBS?
7 ETFs and mutual funds hold it among their top 100 positions, including AATIX, FTMSX, JASCX, MYLD.